How to use Tamoximed Balkan Pharmaceuticals
Tamoximed Balkan Pharmaceuticals is an anti-estrogen used by men when taking steroids that are prone to aromatisation. The drug helps to reduce the damage that excess oestrogen in the body causes to health. It is the main component in the composition of post-cycle therapy. The active substance is tamoxifen.
Main effects of Tamoximed Balkan 20mg
The drug works as follows:
- it binds to oestrogen receptors;
- stimulates the increased production of gonadoliberin;
- increases the production of LH and FSH in the pituitary gland.
This process stimulates the production of testosterone in the testes.
This action allows the body to restore the natural testosterone production that suffers after taking anabolic steroids. In addition, taking an anti-estrogen will help prevent problems such as gynecomastia, bloating, female-type fat deposits, high blood pressure and others.
Possible negative effects
The drug has its drawbacks. It is toxic to the liver and can cause digestive upset. It also increases the risk of thrombosis. It is not taken if active progestin steroids, such as nandrolone, have been used. In such cases, choose another anti-oestrogen.
Tamoxifen inhibits the production of insulin-like growth factor, which is necessary for muscle growth. It also increases the amount of globulin, and is a substance that binds to sex hormones. All this explains why the efficacy of a steroid cycle may decrease with the use of anti-estrogens.
Rules of course construction
Tamoximed Balkan Pharmaceuticals must be included during the steroid cycle. As a general rule, this is done in the last week of the course or in the second week after the start of the course (depending on the drugs used). After the steroid is withdrawn, tamoxifen is taken for another 2 to 3 weeks, as indicated.
The average dose is 10-20 mg. The drug is available in tablet form. This remedy contains 20 mg in 1 tablet. You need to take it every day.
Before use, check if you have any contraindications. To verify the effectiveness of PCT, it is necessary to pass tests, check the level of natural testosterone and estrogen.
List of references
- Jordan, V. C. (2003). Tamoxifen: A most unlikely pioneering medicine. Nature Reviews Drug Discovery, 2(3), 205-213.
- Fisher, B., Costantino, J. P., Wickerham, D. L., Redmond, C. K., Kavanah, M., Cronin, W. M., … & Dignam, J. (1998). Tamoxifen for the prevention of breast cancer: Current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. Journal of the National Cancer Institute, 90(18), 1371-1388.
- Goss, P. E., Ingle, J. N., Pritchard, K. I., Robert, N. J., Muss, H. B., Gralow, J., … & Gelmon, K. A. (2016). Extending aromatase-inhibitor adjuvant therapy to 10 years. New England Journal of Medicine, 375(3), 209-219.
- Cuzick, J., Sestak, I., Cella, D., Fallowfield, L., & ATAC/LATTE investigators. (2010). Treatment-emergent endocrine symptoms and the risk of breast cancer recurrence: A retrospective analysis of the ATAC trial. The Lancet Oncology, 11(8), 717-728.
- Howell, A., Cuzick, J., Baum, M., Buzdar, A., Dowsett, M., Forbes, J. F., … & Veronesi, U. (2005). Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years’ adjuvant treatment for breast cancer. The Lancet, 365(9453), 60-62.